Does SBRT improve the Pembrolizumab response rate?

Multisite stereotactic body radiotherapy followed by PD-1 inhibition with pembrolizumab may be an effective option for some patients with advanced solid tumours, according to a study published in the Journal of Clinical Oncology.
Cancer Therapy Advisor

Leave a Reply

  • (will not be published)

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>